Jacques P F, Selhub J, Bostom A G, Wilson P W, Rosenberg I H
Jean Mayer U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111, USA.
N Engl J Med. 1999 May 13;340(19):1449-54. doi: 10.1056/NEJM199905133401901.
In 1996, the Food and Drug Administration issued a regulation requiring all enriched grain products to be fortified with folic acid to reduce the risk of neural-tube defects in newborns. Fortification (140 microg per 100 g) began in 1996, and the process was essentially complete by mid-1997.
To assess the effect of folic acid fortification on folate status, we measured plasma folate and total homocysteine concentrations (a sensitive marker of folate status) using blood samples from the fifth examination (January 1991 to December 1994) of the Framingham Offspring Study cohort for baseline values and the sixth examination (January 1995 to August 1998) for follow-up values. We divided the cohort into two groups on the basis of the date of their follow-up examination: the study group consisted of 350 subjects who were seen after fortification (September 1997 to March 1998), and the control group consisted of 756 subjects who were seen before fortification (January 1995 to September 1996).
Among the subjects in the study group who did not use vitamin supplements, the mean folate concentrations increased from 4.6 to 10.0 ng per milliliter (11 to 23 nmol per liter) (P<0.001) from the baseline visit to the follow-up visit, and the prevalence of low folate concentrations (<3 ng per milliliter [7 nmol per liter]) decreased from 22.0 to 1.7 percent (P< 0.001). The mean total homocysteine concentration decreased from 10.1 to 9.4 micromol per liter during this period (P<0.001), and the prevalence of high homocysteine concentrations (>13 micromol per liter) decreased from 18.7 to 9.8 percent (P<0.001). In the control group, there were no statistically significant changes in concentrations of folate or homocysteine.
The fortification of enriched grain products with folic acid was associated with a substantial improvement in folate status in a population of middle-aged and older adults.
1996年,美国食品药品监督管理局发布一项规定,要求所有强化谷物产品添加叶酸,以降低新生儿神经管缺陷的风险。强化措施(每100克添加140微克叶酸)于1996年开始实施,到1997年年中基本完成。
为评估叶酸强化对叶酸状态的影响,我们利用弗雷明汉后代研究队列第五次检查(1991年1月至1994年12月)的血样测量血浆叶酸和总同型半胱氨酸浓度(叶酸状态的敏感标志物)作为基线值,并利用第六次检查(1995年1月至1998年8月)的血样测量随访值。我们根据随访检查日期将队列分为两组:研究组由350名在强化后接受检查的受试者组成(1997年9月至1998年3月),对照组由756名在强化前接受检查的受试者组成(1995年1月至1996年9月)。
在研究组中未服用维生素补充剂的受试者中,从基线访视到随访访视,叶酸平均浓度从每毫升4.6纳克增至10.0纳克(11至23纳摩尔/升)(P<0.001),低叶酸浓度(<3纳克/毫升[7纳摩尔/升])的患病率从22.0%降至1.7%(P<0.001)。在此期间,总同型半胱氨酸平均浓度从每升10.1微摩尔降至9.4微摩尔(P<0.001),高同型半胱氨酸浓度(>13微摩尔/升)的患病率从18.7%降至9.8%(P<0.001)。在对照组中,叶酸或同型半胱氨酸浓度无统计学显著变化。
强化谷物产品添加叶酸与中老年人群叶酸状态的显著改善相关。